HC Wainwright Reiterates Buy on Cullinan Therapeutics With $35 Target
HC Wainwright & Co. reiterated a Buy rating on Cullinan Therapeutics (CGEM) with a price target of $35.00, implying a 140.9% upside from the previous close.
HC Wainwright & Co. reiterated a Buy rating on Cullinan Therapeutics (CGEM) with a price target of $35.00, implying a 140.9% upside from the previous close.